Speech Pacesetter is a specialized medical tool for speech pacing therapy, designed for adults and children with neurological speech conditions on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive load of manual pacing by providing a visual, speed-adjustable metronome for speech-language pathologists and patients.
For Adults with neurological speech conditions, older children requiring pacing therapy, and speech-language pathologists.
What does it look like?
Key features
Visual highlights for syllables or words that pace reading speed, justifying the $17.99 price point as a specialized medical tool.
Allows users to save personalized passages, reinforcing the app as a permanent part of a clinical toolkit.
Optional auditory pacing aid that functions alongside visual cues.
How much does it cost?
The single-tier $17.99 model targets clinical professionals but faces resistance from users who perceive the feature set as limited relative to the cost.
Velocity
Dormant developmentopaqueShow more...
Speech Pacesetter has been inactive for 2,244 days, indicating the project is no longer receiving development support. There have been no feature updates, bug fixes, or operational changes in over six years. The development momentum is non-existent, and the app remains in a state of total stagnation.
Who built it?
Aptus Speech and Language Therapy
13+ apps tracked · Medical
Inference Pics Lite
Articulation Arcade Lite
Comprehension Toolbox
Minimal Pairs Arcade Lite: SLP
Turtle Pacing Board
Conversation Paceboard
Inference Pics
Keywords Understanding Lite
Empathy Pics Lite
Keyword Understanding
Articulation Arcade
Verb ToolboxUser Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate the core speech training exercise provides a functional tool for students who stutter and clutter.
How are ratings & reviews evolving?
What users say, by theme
- The core speech training exercise provides a functional tool for students who stutter and clutter
- The current price point feels excessive given the minimal functionality and lack of content variety
4 of 4 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Speech Pacesetter
How's the Medical market?
Speech Pacesetter occupies a niche medical segment, currently ranking #47 Paid in its category in the US. The lack of updates for over 74 months signals a stagnant position that leaves the app vulnerable to multi-modal rivals.
The rivals identified
By Tactus Therapy Solutions Ltd.
This app serves the same clinical medical audience with a comprehensive, multi-modal therapy suite that directly competes for the same professional and patient budget.
- Bundles four distinct therapy tools into one cohesive interface, offering significantly higher value per dollar than single-purpose apps.
- Established clinical reputation provides a strong trust-based moat that makes it the default choice for speech-language pathologists.
The Analyst's Read
Key takeaways for Speech Pacesetter
Where is it heading?
The speech therapy market is consolidating around multi-modal suites that offer higher value per dollar. Speech Pacesetter's maintenance-mode status leaves it exposed to rivals that iterate on UI and content, signaling a continued decline in market share unless the pricing model is modernized.
- The 74-month update drought erodes clinical trust, which compounds the negative sentiment regarding the app's high price point.
- The lack of onboarding guidance in the latest release causes immediate user confusion, leading to higher abandonment rates.
The SWOT
- Specialized visual pacing engine provides a functional, niche-specific tool for speech-language pathologists
- Introducing a freemium entry point could capture users currently deterred by the $17.99 upfront cost
Next best moves
Ship a free-to-try version because the $17.99 price point is the top complaint theme → increase conversion velocity
+ 1 more prioritized moveThe counter-intuitive read
The app's 74-month update silence is a competitive advantage in a clinical setting…
Read the full takeFeature gaps
Multi-modal therapy suite (available in Language Therapy 4-in-1 but missing here) +1
Since the last report: Speech Pacesetter remains in a state of total stagnation, with no development activity recorded for 74 months. The primary shift is a decline in sentiment score from 30 to 25, reflecting intensified user frustration with the lack of onboarding and the $17.99 price point.
Bottom line
The app's clinical utility is currently trapped behind a high-friction paywall and a stagnant interface. A pivot to a freemium model would allow the app to compete for the entry-level therapy market, unlocking the value currently suppressed by the $17.99 barrier.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated